These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1341062)

  • 1. Factor VIII and tissue plasminogen activator in monkeys after administration of DDAVP analogues.
    Vilhardt H; Barth T
    Thromb Res; 1992 Dec; 68(6):501-4. PubMed ID: 1341062
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue plasminogen activator enhancing activity of vasopressin analogues in monkeys: structure-activity study.
    Vilhardt H; Barth T
    J Recept Res; 1993; 13(1-4):305-11. PubMed ID: 8450495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and haematological effects of desmopressin.
    Köhler M; Harris A
    Eur J Clin Pharmacol; 1988; 35(3):281-5. PubMed ID: 3141199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The release of factor VIII and tissue plasminogen activator can not be blocked by specific antagonists to vasopressin.
    Vilhardt H; Barth T
    J Recept Res; 1991; 11(1-4):239-45. PubMed ID: 1909360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of factor VIII after administration of DDAVP to conscious dogs.
    Vilhardt H; Barth T; Falch J; Nilsson IM
    Thromb Res; 1987 Sep; 47(5):585-91. PubMed ID: 3118500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DDAVP on plasma level of factor XII.
    Nenci GG; Berrettini M; De Cunto M; Agnelli G
    Br J Haematol; 1983 Jul; 54(3):489-92. PubMed ID: 6407513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiuretic activity and release of factor VIII by vasopressin analogues.
    Vilhardt H; Barth T; Melin P; Aurell CJ
    Eur J Pharmacol; 1993 Mar; 232(2-3):223-6. PubMed ID: 8467859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) in normal individuals (author's transl)].
    Takahashi H; Itoh M; Kobayashi I; Hattori A; Takahashi K; Sakuragawa N; Shibata A; Tsukada T
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):907-17. PubMed ID: 6785953
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII-related activities after 1-deamino-8-D-arginine vasopressin in multicentric reticulohistiocytosis.
    Taddeo U; Trotta F; Menegale G; Ballerini G
    Ric Clin Lab; 1984; 14(1):37-9. PubMed ID: 6427880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihaemophilic effect of vasopressin, deamino-(D-arginine8)-vasopressin and adrenaline in sheep: proposal for an in vivo assay system.
    Heiniger J; Kissling-Albrecht L; Neuenschwander S; Rösli R; Pliska V
    Br J Pharmacol; 1988 Jun; 94(2):279-81. PubMed ID: 3134968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
    Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial stimulation by DDAVP in von Willebrand's disease and haemophilia.
    Greer IA; McLaren M; Belch JJ; Lowe GD; Forbes CD
    Haemostasis; 1986; 16(1):15-9. PubMed ID: 3084364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 18. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor.
    Muhm M; Grois N; Kier P; Stümpflen A; Kyrle P; Pabinger I; Bettelheim P; Hinterberger W; Lechner K
    Haemostasis; 1990; 20(1):15-20. PubMed ID: 2108912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor.
    Patrassi GM; Sartori MT; Casonato A; Viero ML; Pontara E; Saggiorato G; Girolami A
    Thromb Res; 1992 Jun; 66(5):517-26. PubMed ID: 1523608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal response to DDAVP in patients with plathology of the hypothalamoneurohypophyseal axis.
    Vincente V; Corrales J; Miralles J; Alberca I
    Thromb Res; 1987 Mar; 45(5):695-7. PubMed ID: 3109066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.